Bath & Body Works (NYSE:BBWI) Releases Q1 2025 Earnings Guidance

Bath & Body Works (NYSE:BBWI) issued an update on its first quarter 2025 earnings guidance on Thursday morning. The company provided EPS guidance of 0.360-0.430 for the period, compared to the consensus EPS estimate of 0.440. The company issued revenue guidance of $1.4 billion-$1.4 billion, compared to the consensus revenue estimate of $1.4 billion. Bath & Body Works also updated its FY 2025 guidance to 3.250-3.600 EPS.

Analysts Set New Price Targets

A number of research analysts have weighed in on BBWI shares. TD Cowen boosted their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the company a “buy” rating in a research report on Thursday, December 12th. Wells Fargo & Company raised shares of Bath & Body Works from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. Telsey Advisory Group reaffirmed an “outperform” rating and set a $43.00 target price on shares of Bath & Body Works in a research note on Thursday. Raymond James restated an “outperform” rating and set a $46.00 price objective (up previously from $42.00) on shares of Bath & Body Works in a report on Tuesday. Finally, Morgan Stanley decreased their target price on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a research report on Thursday, November 21st. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $45.38.

Bath & Body Works Trading Up 0.9 %

Bath & Body Works stock traded up $0.31 during midday trading on Friday, hitting $36.17. 3,136,003 shares of the stock were exchanged, compared to its average volume of 3,663,079. The stock has a market capitalization of $7.83 billion, a price-to-earnings ratio of 8.82, a PEG ratio of 0.92 and a beta of 1.83. The stock’s 50-day simple moving average is $37.76 and its 200 day simple moving average is $34.08. Bath & Body Works has a fifty-two week low of $26.20 and a fifty-two week high of $52.99.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 EPS for the quarter, beating analysts’ consensus estimates of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to analysts’ expectations of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. Equities analysts anticipate that Bath & Body Works will post 3.3 EPS for the current fiscal year.

Bath & Body Works Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a $0.20 dividend. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.21%. Bath & Body Works’s dividend payout ratio is currently 19.51%.

Bath & Body Works declared that its board has initiated a share buyback plan on Thursday, February 27th that authorizes the company to repurchase $500.00 million in shares. This repurchase authorization authorizes the company to repurchase up to 6.4% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.